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Subani Chandra1, Pralay K Sarkar1, Divay Chandra2, Nicole E Ginsberg1 and Rubin I Cohen1*Abstract
Background: The increased use of computed tomography pulmonary angiography (CTPA) is often justified by
finding alternative diagnoses explaining patients’ symptoms. However, this has not been rigorously examined.
Methods: We retrospectively reviewed CTPA done at our center over an eleven year period (2000 – 2010) in
patients with suspected pulmonary embolus (PE). We then reviewed in detail the medical records of a
representative sample of patients in three index years – 2000, 2005 and 2008. We determined whether CTPA
revealed pulmonary pathology other than PE that was not readily identifiable from the patient’s history, physical
examination and prior chest X-ray. We also assessed whether the use of pre-test probability guided diagnostic
strategy for PE.
Results: A total of 12,640 CTPA were performed at our center from year 2000 to 2010. The number of CTPA
performed increased from 84 in 2000 to 2287 in 2010, a 27 fold increase. Only 7.6 percent of all CTPA and 3.2
percent of avoidable CTPAs (low or intermediate pre-test probability and negative D-dimer) revealed previously
unknown findings of any clinical significance. When we compared 2008 to 2000 and 2005, more CTPAs were
performed in younger patients (mean age (years) for 2000: 67, 2005: 63, and 2008: 60, (p=0.004, one–way ANOVA)).
Patients were less acutely ill with fewer risk factors for PE. Assessment of pre-test probability of PE and D-dimer
measurement were rarely used to select appropriate patients for CTPA (pre-test probability of PE documented in
chart (% total) in year 2000: 4.1%, 2005: 1.6%, 2008: 3.1%).
Conclusions: Our data do not support the argument that increased CTPA use is justified by finding an alternative
pulmonary pathology that could explain patients’ symptoms. CTPA is being increasingly used as the first and only
test for suspected PE.Background
Computed tomography pulmonary angiography (CTPA)
is the preferred method to confirm or exclude a PE.
However the non-selective use of CTPA has several dis-
advantages. These include long term risks of exposure to
high doses of radiation and a small but definite risk of
kidney injury due to intravenous contrast. Moreover,
CTPA is an expensive test and often leaves behind a trail
of incidental findings of indeterminate implication that
further increase health care costs [1,2]. Even with
CTPA’s technological advances, easy availability and ever
shorter scan times, the assessment of clinical pre-test* Correspondence: rocohen@nshs.edu
1Division of Pulmonary, Critical Care and Sleep Medicine, The Long Island
Jewish Medical Center, The Hofstra North Shore-LIJ School of Medicine, New
Hyde Park, New York, NY 11040, USA
Full list of author information is available at the end of the article
© 2013 Chandra et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the orprobability remains central to the diagnosis of PE and
ideally should influence the initial choice of diagnostic
testing [3-5]. However, it remains unclear how fre-
quently pre-test probability algorithms are followed in
daily clinical practice [6-8]. Furthermore, while the num-
ber of CTPA has increased dramatically, the majority of
CTPA do not show the presence of PE. Nevertheless,
the increase in the use of CTPA is often justified by the
discovery of hitherto unknown pathological etiologies
[9-13]; however, review of the literature would indicate
that this has not been rigorously examined. In this study
we examined the patterns of CTPA use over an eleven
year period at a single center and assessed whether the
use of CTPA was justified in those with low or inter-
mediate pre-test probability by the finding of an alterna-
tive diagnosis that might have explained the patient’s
symptoms.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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We determined the total number of CTPA performed in
patients >18 years in age, and their results (as either
positive or negative for PE) for each year from 2000–
2010 in a 500 bed, academic teaching hospital in New
York City. The study was approved by the North Shore-
Long Island Jewish Health System’s institutional review
board which waived the need for informed consent.
We studied in detail, the medical records of patients
who underwent CTPA in three index years 2000, 2005,
and 2008. We chose the year 2000 as a baseline refer-
ence year, the year 2005 was the first calendar year after
the hospital obtained an additional CT scanner, and the
year 2008 followed the publication of Prospective Inves-
tigation of Pulmonary Embolism Diagnosis II (PIOPED
II) and its recommendations [3-5,14]. We reviewed all
available records for the year 2000 (74 records) and a
random sample representative of all CTPA performed in
2005 and 2008. A total of 850 studies were reviewed for
2005 and 2008. We excluded CT chest angiograms
performed for other reasons such as aortic dissection.
Demographic data, clinical presentation, risk factors for
thromboembolic disease, documentation of pre-test
probability of PE, use of therapeutic anticoagulation, and
results of CTPA were abstracted from patients’ med-
ical records. Since increased use of CTPA may be re-
placing that of V/Q scans, we also determined the
number of V/Q scans performed for the diagnosis of PE
from 2000 to 2010.
Assessment of pre-test probability of PE
We assigned pre-test probability to all subjects using the
Revised Geneva Score (RGS) [15]. At the time of assign-
ment of pre-test probability, the investigators were
blinded to the results of the CTPA. Based on the RGS
we assigned subjects to low (RGS 0–3), intermediate
(RGS 4–10), and high (RGS ≥ 11) pre-test probability
categories. CTPA performed on patients who were in
the low or intermediate pre-test probability category and
had a negative D-dimer were considered avoidable.
D-dimer measurement
In 2000 and 2005, D-dimer was measured by quantita-
tive latex agglutination and in 2008 by ELISA (Enzyme-
linked immunosorbent assay) with fluorescence (ELFA)
(VIDAS W D-dimer Exclusion TM, bioMérieux, Marcy
l'Etoile, France). The D-dimer assay is readily avail-
able in our hospital and the results are reported within
30 minutes.
CT pulmonary angiography
In 2000, CTPAs were performed on single or 4 – slice
scanners (HiSpeed, GE Healthcare, UK). In 2005 another
4-slice CT scanner (HiSpeed, GE Healthcare, UK) wasinstalled and the existing CT scanners were upgraded to
16-slice CT machines (LightSpeed, GE Healthcare, UK).
In 2008, all CTPA were being performed on 16-slice
scanners (LightSpeed and BrightSpeed, GE Healthcare,
UK). Central PE was defined as PE in the pulmonary
trunk, right or left main pulmonary arteries or lobar ar-
teries while PE in segmental or sub-segmental branches
were considered peripheral.
Sample size calculation
We used an estimate of the proportion of patients who
had a CTPA and were in the low probability group for
the sample size calculations. Statistically, the most con-
servative calculation occurs if 50% of patients fall into
this category. We imposed a constraint to estimating
within 5 percentage points of the expected proportion
since the sample size for the years 2005 and 2008 was so
large. For a sample size of 385, a two-sided 95% confi-
dence interval for a single proportion is no wider than ±
5.0% from an expected overall proportion of 50% (i.e. 45%
to 55%). Based on this estimate a random sample of 383
and 393 CTPA were reviewed for 2005 and 2008 respect-
ively. We reviewed all available CTPA results (74 of 84)
for the year 2000.
Statistical analyses
All analyses were performed using Stata 11.1 (StataCorp
LP, College Station, TX). Chi-square tests were used for
categorical data, while one-way ANOVA was used for
continuous variables. A two-tailed p-value < 0.05 was
considered statistically significant.
Results
Over the study period (2000 to 2010), there was a 27-
fold increase in the total number of CTPA (Figure 1)
without a corresponding increase in yield. The total
number of CTPA in the three index years 2000, 2005
and 2008 were 84, 1114 and 2287 respectively. While
the number of CTPA ordered increased in all depart-
ments, the ED had the largest increase. The numbers of
scans performed in the ED per 100 visits were 0.14 in
2000, 1.82 in 2005 and 2.58 in 2008. The ED also had
the steepest decline in the percentage of scans positive
for PE (Figure 2).
Justification for CTPA
We assessed whether the use of CTPA is justified in
those with low or intermediate pre-test probability by
the finding of an alternative diagnosis that might explain
the patient’s symptoms. The frequency of alternate diag-
noses found on CTPA was as follows: ED: 10%, Medi-
cine: 5%, Surgery: 3%; p = 0.08. When we examine the
data more closely, only 3.2% of potentially avoidable
CTPA (low or intermediate pre-test probability and
0200
400
600
800
1000
1200
1400
1600
1800
2000
2200
2400
22.6%
27.3%
25.7%
13.7%
15.4%
14.5%
12.6%
10.9%
14.8%
N
u
m
b
er
 o
f 
 C
T
 a
n
g
io
g
ra
m
s
Calendar Year
13.0 %
15.0 %
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Figure 1 The number of CTPA performed per calendar year from 2000 to 2011. The dark bars and percentages are the CTPA that were
positive for PE.
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http://www.biomedcentral.com/1471-2466/13/9negative D-dimer) had an alternative diagnosis that was
neither previously known nor evident on a chest radio-
graph performed prior to the CTPA.
Findings on prior chest X-ray
13% of the patients did not have a prior chest X-ray
defined as within 48 hours of CTPA. Among those who
did undergo a chest X-ray, the findings were as follows:
40% normal, 14% pleural effusion, 11% pulmonary
edema, 6% atelectasis, 6% infiltrate, and 10% other.
Patients undergoing CTPA
In contrast to 2000 and 2005, those undergoing CTPA
in 2008 were significantly younger and less acutely ill as16.2%
28.1%
40.0%
32.1%
2
Figure 2 Number of CTPA by hospital department for the index years
emergency department (ED) which also had the steepest decline in positivevidenced by their higher oxygen saturation and lower
respiratory rate (Table 1). Moreover, patients in 2008
were much less likely to have any risk factors for throm-
bosis or a prior history of venous thromboembolism.
There was an increase in the use of CTPA in patients
with chest pain, and for “other” indications (Table 1).
The increase in number of scans ordered was accompan-
ied by a significant drop in the diagnosis of PE from
22.6% in 2000 to 13% in 2010. We also noted a change in
the size and location of pulmonary emboli detected over
time: in 2008, a greater proportion of PE was found distal
to the lobar arteries in the segmental or sub segmental
branches (Table 2). Since younger patients and women
may be more at risk from the potential carcinogenic0.4%
18.5%
45.4%
26.9% 28.0%
Negative for PE
Positive for PE
2000, 2005 and 2008. The largest increase occurred in the
e yield (% above bars).
Table 1 Demographics, signs and symptoms, risk factors and prior medical history by year for 850 patients
undergoing CT angiography
Characteristics 2000 2005 2008 Total p
n 74 383 393 850
Demographics
Age (years) (mean ± SD) 66.8 ± 16.8 62.9 ± 17 60 ± 19.3 61.9 ± 18.2 0.004
Female (%) 59.5 65 67.9 65.9 0.33
Females < 40 years (%) 6.8 7.8 16.5 11.8 0.004
Body mass index (kg/m2) (mean ± SD) 27.3 ± 5.5 27.4 ± 7.2 27.8 ± 6.2 27.6 ± 6.7 0.760
Signs and symptoms
Shortness of breath (%) 79.7 63.7 62.3 64.5 0.015
Chest pain (%) 27 38.9 50.1 43.1 <0.001
Palpitations (%) 5.5 1.3 3.3 2.6 0.06
Syncope (%) 2.7 1 3.8 2.5 0.04
Hypoxia (%) 13.7 6.5 10.2 8.8 0.06
Cough (%) 9.5 9.9 12 10.8 0.60
Hemoptysis (%) 1.4 0.3 3.6 1.9 0.003
Lower extremity pain (%) 4.1 0 5.9 3.1 <0.001
Leg edema/tenderness (%) 1.4 0 8.9 4.2 <0.001
Other (%) 14.9 10.2 27.2 18.5 <0.001
Systolic blood pressure (mmHg) 128 ± 27 131 ± 23 129 ± 22 130 ± 23 0.389
Diastolic blood pressure (mmHg) 73 ± 13 75 ± 15 73 ± 14 74 ± 14 0.19
Respiratory rate (/min) 23.8 ± 7.5 20.7 ± 6 20 ± 5.7 20.6 ± 6 <0.001
Oxygen saturation (%) 92.7 ± 6.8 94.1 ± 6 95.3 ± 9.6 94.5 ± 8 0.01
Requiring supplemental O2 (%) 40.5 22.1 19 22.3 <0.001
Risk factors for thrombosis (%)
Immobility 31.1 24.8 15.8 21.2 0.001
Active malignancy 31.1 29.8 22.1 26.4 0.03
Hospitalized in the prior 4 weeks 38.4 34.7 28.3 32.1 0.08
Surgery in the prior 4 weeks 25.7 17 16.3 17.4 0.14
Prior PE or DVT 17.6 9.4 12.5 11.5 0.01
Pregnant 1.4 1.6 5.1 3.2 0.01
Known hypercoagulable disorder 0 1.6 1 1.2 0.48
On estrogen therapy 6.8 1.8 3.6 3.1 0.06
Prior medical history (%)
Any lung disease 29.7 26.4 24.4 25.8 0.58
Hypertension 48.7 16.5 51.2 35.3 <0.001
Coronary artery disease 27 18.5 23.2 21.4 0.14
Congestive heart failure 18.9 6 6.6 7.4 <0.001
Other cardiac disease 25.8 6.8 13.5 11.5 0.26
Dialysis 0 1.3 2.3 1.7 0.28
Transferred from another institution 8.2 11.5 8.4 9.8 0.31
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Table 2 CTPA positivity rate and location of pulmonary
emboli
CTPA Results 2000 2005 2008 Total p
n 74 383 393 850
Embolus present (%) 25.7 19.1 14.8 17.7 0.048
Location of embolus
for positive studies (%)
Central PE 89.6 46.6 51.8 53.9 0.003
Peripheral PE 10.5 53.4 48.3 46
Central PE was defined as PE in the pulmonary trunk, right or left main
pulmonary arteries or lobar arteries while PE in segmental or sub-segmental
branches were considered peripheral.
There was no correlation between pre-test probability by RGS and location or
size of PE.
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http://www.biomedcentral.com/1471-2466/13/9effects of ionizing radiation [16], we also examined age
and gender in our sample. The number of CTPA per-
formed on women under the age of 40 years increased sig-
nificantly over the study period (Table 1). While 11.8% of
all CTPAs performed were on women less than 40 years
of age, the presence of a PE in this cohort was lower than
in all CTPAs reviewed (9.1% versus 17.7%).
Pre-test probability
Across all years, physicians ordering CTPA rarely docu-
mented the pre-test probability of PE in the patients’
medical records (Table 3). Our calculation of pre-test
probability based on the RGS showed that more patients
with low pre-test probability of PE underwent CTPA in
later years (Table 3). Overall, PE was present on CTPA
in 9.3% of patients with a low pre-test probability, 20.9%
patients with an intermediate pre-test probability and
29.6% with a high pre-test probability of PE. Slightly
over one fifth (22.2%) of patients with a high pre-test
probability of PE received any form of anticoagulation
prior to undergoing CTPA.
Use of D-dimer
D-dimer was assessed in an increasing number of
patients with low or intermediate pre-test probability of
PE. In 2000, no patient with a low or intermediate RGS
underwent a D-dimer test. In 2005 this number was
21.3% and in 2008 was 31.9%. Notably, our data showTable 3 Assessment of clinical pre-test probability and RGS
2000
n 74
Pre-test probability of PE documented (%) 4.1
Calculated Revised Geneva Score (mean ± SD) 5.7 ± 2.9
Low probability (%) 25.7
Intermediate probability (%) 70.3
High probability (%) 4.1that when the D-dimer was negative in such patients
and PE was not diagnosed on CTPA (Table 4). Among
those with high pre-test probability, the D-dimer was al-
ways positive when performed.
V/Q scanning
Since the increase in CTPA may be mirrored by a corre-
sponding decrease in V/Q scans, we were interested as
to whether the number of V/Q performed for the diag-
nosis of PE decreased accordingly (Figure 3). The instal-
lation and availability of another CT scanner in 2005
resulted in 19% drop in V/Q scans compared to 2000.
By 2008, the number of V/Q scans being performed for
the diagnosis of PE dropped by 31% compared to 2005
(Table 5), and by 44% compared to 2000. Table 5 also
illustrates the changes in ED visits and hospital admis-
sions for the index years 2000, 2005 and 2008.
Discussion
From the year 2000 to 2010, the total number of CTPA
performed at our center increased exponentially al-
though the percentage of scans positive for PE declined.
This increase in CTPA was not accompanied (or justi-
fied) by finding an alternative diagnoses on CTPA that
explains the patients’ symptoms. Indeed, our data indi-
cate that CTPA rarely reveals a previously unknown or
new finding especially in those with low and intermedi-
ate risk for PE. CTPA provided an alternate diagnosis,
defined as one that was not previously known or evident
on chest radiograph in only 7.6% of all non-PE CTPA.
Additionally, this number would drop to 3.2% had the
published guidelines for investigation of suspected PE
been followed, that is in those with low or intermediate
pre-test probability and a negative D dimer. We also find
that CTPAs were being performed in younger patients
even in the absence of symptoms and identifiable PE risk
factors further negating the argument of discovering an
alternative pathological diagnosis. Finally, the increase in
the number of CTPA corresponds neither to the de-
crease in the number of V/Q scans nor to the increase
in the number of ED visits or hospital admissions.
The utility of CTPA to provide an alternative diagnosis
is often cited as justification for obtaining this test even2005 2008 Total p
383 393 850
1.6 3.1 2.4 0.48
5.3 ± 2.5 5.4 ± 3.0 5.4 ± 2.8 0.42
24.5 28.8 26.6
0.0174.4 66.2 70.2
1 5.1 3.2
Table 4 Use of D-dimer in patients undergoing CTPA
Pre-test
probability n
D-dimer not performed, %
(CTPA positive %)
D-dimer performed
Negative D-dimer, % (CTPA positive, %) Positive D-dimer, % (CTPA positive, %)
Low
2000 19 100.0 (100) - -
2005 94 78.7 (6.8) 4.3 (0) 17 (0)
2008 113 68.1 (16.9) 7 (0) 24.8 (7.1)
Intermediate
2000 52 98.1 (33.3) 1.9 (0) -
2005 285 81.0 (23.8) 1.8 (0) 17.2 (24.5)
2008 260 79.2 (15.5) 4.6 (0) 16.2 (21.4)
High
2000 3 100.0 (66.7) - -
2005 4 75.0 (33.3) - 25 (100)
2008 20 85.0 (23.5) - 15 (0)
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http://www.biomedcentral.com/1471-2466/13/9when PE is not found [9-15]. In prior studies, the most
frequently cited alternative diagnosis on CTPA is an in-
filtrate or consolidation suggestive of pneumonia. How-
ever, it is not recorded whether a history and physical
examination had already suggested pneumonia; neither
was it noted whether a chest radiogram was performed
prior to the CTPA. While it is difficult to compare stud-
ies as purpose, setting and design differ, one retrospect-
ive study reported a third of CTPAs revealed an
alternative explanation of the patient’s presenting symp-
toms but such findings were already known in over half
of patients from the admission chest radiogram [9,17].
In our center, 40% of the chest X-rays performed prior
to the CTPA were interpreted as normal, while in 13%
of patients a chest film was not obtained within 48 hours2000 2001 2002 2003 2004
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Figure 3 Number of ventilation-perfusion scans (V/Q) performed for tof ordering the CTPA. This indicates that in just fewer
than half the patients (47%) a pathological diagnosis was
present on the chest film. Clearly the presence of a
radiological process on chest X-ray does not rule out the
concomitant presence of PE, and we cannot determine
what the ordering physician was considering. However
the combination of diminishing yield of the CTPA from
2000 to 2010, the younger and healthier patients on
whom CTPA is being performed, the underutilization of
pre-tests probability and D-dimer, the presence of
known lung pathology on a chest film, the drop in V/Q
scans not matched by the increase in the number of
CTPAs, all attest to the unjustified overuse of CTPA.
Accepted recommendations for the diagnosis of PE
continue to emphasize pre-test probability to guide theYEAR
2005 2006 2007 2008 2009 2010
571
618
413
392
354
412
he diagnosis of PE from 2000 to 2012.
Table 5 Trend in number of CTPAs and V/Q scans
performed, as well as ED visits and hospital admissions
for the years 2000, 2005 and 2008
2000 2005 2008 % change
2000 - 2005
% change
2005 - 2008
CTPA 84 1114 1883 1226 69
V/Q scan 699 571 392 −18 −31
ED visits 41,464 41,004 48,813 −1 19
Hospital
admissions
42,483 41,398 45,770 −3 10
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http://www.biomedcentral.com/1471-2466/13/9choice of testing, and the positive predictive value of
CTPA remains dependent on the pre-test probability of
PE [3-5]. We used documentation of pre-test probability
in patients’ medical records as a surrogate for assign-
ment of pre-test probability by any means, subjective or
objective. It is possible that assessment of pre-test prob-
ability was performed by physicians prior to CTPA, but
not specifically recorded. However, if this were the case,
such assessment of pre-test probability occurred in a ra-
ther small minority of patients for the following two rea-
sons. First, D-dimer was only measured in 20% of all
patients with a low or intermediate pre-test probability
of PE. Second, only 1 in 5 patients in the high pre-test
probability category received anticoagulation while
awaiting confirmation of PE with a CTPA. Our study
was designed to investigate the rates and indications for
the use of CTPA in clinical practice and therefore only
includes patients undergoing CTPA. It is possible that
patients presented with low risk for PE, were appropri-
ately screened and did not undergo CTPA. We believe
that such number is small as our data reveal that
younger patients with fewer risk factors for PE were
undergoing CTPA.
We assigned pre-test probability retrospectively using
the RGS that tends to classify the great majority of
patients in the low or intermediate categories and this
could limit the interpretability of our findings. However,
the limitation of the RGS notwithstanding, it is suited
for retrospective calculation and variables included in
the RGS can be accurately assessed by systematic chart
review (25).
The British Thoracic Society’s guidelines advise that
should a PE be suspected, the patient should be fully
evaluated by an experienced middle-grade doctor (the
equivalent of a resident in their third year of training) so
that alternative diagnoses are considered and clinical
probability for PE is documented. Such practice should
then yield a 25% incidence of PE when CTPA is per-
formed [7]. Our data show that CTPA yields a positive
diagnosis in only 11% to 15% of all CTPAs. Though sub-
jective assessment by experienced physicians has been
shown to be non-inferior to objective assignment of pre-test probability, unfortunately, the present trend in
ordering CTPA could make it unlikely for such expertise
in the clinical diagnosis of PE to develop. Not only are
recommendations not being followed in routine clinical
practice, but a greater proportion of CTPA are being
performed in patients with lower pre-test probability
and on younger and seemingly healthier patients. As
guidelines outline how to best utilize CTPAs [3-5,14]
and articles lament the over use of CTPAs [8,17-21],
Glaser and colleagues demonstrated that a simpler
reporting strategy for V/Q scans (PE present, PE absent
and non-diagnostic) can be safely implemented, facili-
tates clearer communication with referring clinicians
and may reduce the number of CTPAs ordered [22].
It is possible that the results of this study are isolated
to our medical center; however, this is highly suspect.
There is little reason to indicate that practice at our cen-
ter would differ from national practice, especially upon
reviewing the literature. Other studies, albeit smaller and
covering a shorter time span, are consistent with a dra-
matic increase in CTPA use [6,7]. Yin and colleagues
[23] also found that D-dimer assay was not being used
appropriately in a one year evaluation of CTPAs per-
formed in their institution. The increase in CT
utilization by our ED is by no means unique; indeed the
overall use of CT scan in the ED had risen by 14% a year
since 1995 and by 330% from 1996 to 2007 [18,24].Conclusion
In conclusion, our data indicate that search for an alter-
nate radiologic diagnosis does not justify what appears
to be an indiscriminate use of CTPA. CTPA is being in-
creasingly used as the first and only diagnostic test for
suspected PE and the frequency of positive CTPAs has
declined significantly over time, with younger and
healthier patients being tested.
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